chrisvoncsefalvay/vaers-outcomes huggingface dataset:
my whole body was stabbed with thousand needles; sore arm; chills; major body aches; fever; This spontaneous case was reported by a consumer and describes the occurrence of PAIN (my whole body was stabbed with thousand needles), VACCINATION SITE PAIN (sore arm), CHILLS (chills), MYALGIA (major body aches) and PYREXIA (fever) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 004M20A) for COVID-19 vaccination.     No medical history was provided by the reporter.     On 27-Jan-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 28-Jan-2021, the patient experienced PAIN (my whole body was stabbed with thousand needles), VACCINATION SITE PAIN (sore arm), CHILLS (chills), MYALGIA (major body aches) and PYREXIA (fever). At the time of the report, PAIN (my whole body was stabbed with thousand needles), VACCINATION SITE PAIN (sore arm), CHILLS (chills), MYALGIA (major body aches) and PYREXIA (fever) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Body temperature: 100.1f (Inconclusive) 100.1F.         Reporter did not allow further contact
The patient started to sweat right before I was about to give the vaccine. The patient claimed she wanted me to go ahead and give it. After I gave the vaccine, the patient seemed fine but started vomiting 2 minutes later. She expressed that it was probably just due to having anxiety of receiving the vaccine. The patient sat down for about 15 minutes and left with no issues.
Not really an adverse event, but I had Mild COVID several days after vaccine per below....  09/08 - received my second booster (Moderna Bivalent) 09/11 - Attended Concert 09/13 - Evening.  Symptoms noticed. Runny nose Scratchy throat. 09/14  - Took an at Home COVID test at 8 am and tested positive. 09-14 - Scheduled and did a Facetime call with my family Doctor and went over symptoms and Options.  Decided not to take Paxlovid, unless symptoms worsened. 09/14 - 09/17 - Mild symptoms of running nose and sore throat diminished.  I was never congested or had mucus in chest, no trouble breathing. 09/18 - Feeling totally fine by 09/18,  no real symptoms, occasional need to blow nose.
Large (approx 3 1/2" dia.) swollen, reddish brown lump at the injection area. Soreness became worse and went to emergency room three days later. Swelling has reduced to 1/2" dia. but other reaction, abdominal pain has increased greatly. Also initially had tingly sensation in hand and fatigue but has decreased.
This is a spontaneous report from a contactable consumer. This consumer reported for a female patient (mother) that a female patient of unspecified age received bnt162b2 (PFIZER Covid 19 vaccine mRNA, Solution for injection, Batch/Lot number- unknown Expiry Date-Unknown) via an unspecified route of administration on unknown date around 04:00 as DOSE 1, SINGLE for covid-19 immunisation. The patient medical history and concomitant medication were not reported. On an unspecified date patient experienced Headache, Body aches, Pain on the back of the shoulders and diaphragm, Lot of pressure on the stomach. It was reported that patient is 86 (not clarified) took the first dosage of the vaccine (Covid vaccine) on Thursday around 4 o'clock and she was fine for first 24 to 36 hours and then she started getting a little bit of headache and body aches, no fever. But today, most of the last night and today she has a little bit of, she is complaining of the pain on the back of the shoulders and diaphragm, a lot of pressure on the stomach, she still has no fever, her blood pressure is good. I gave her two Tylenol (treatment) at about 11:15 in the morning central time. I just want to make sure that even though it has been more than 48 hours that these are still could be fine side effects from the vaccine. "Patient received two Tylenol (treatment) at about 11:15 in the morning central time. Reporter just want to make sure that even though it had been more than 48 hours that these are still could be fine side effects from the vaccine. Patient underwent lab test and procedures include blood pressure result good on an unspecified date. The outcome of event were unknown. No follow-up attempts are possible. Information about Lot/Batch number cannot be requested. No further information is expected.
Swelling of lymph nodes; This spontaneous case was reported by a consumer and describes the occurrence of LYMPHADENOPATHY (Swelling of lymph nodes) in a 52-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On 18-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 24-Jan-2021, the patient experienced LYMPHADENOPATHY (Swelling of lymph nodes). At the time of the report, LYMPHADENOPATHY (Swelling of lymph nodes) outcome was unknown.      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   Concomitant medications have not been reported.  Treatment information not provided.
Patient had intermittent diarrhea and vomiting for the 2-3 weeks following his first COVID vaccine. He also had diarrhea/vomiting the day after his second COVID vaccine.
After immunization and PPD, patient complained of nausea, felt warm.  BP 106/78, and dizziness, pulse 84, drank a lot of water - no nausea, no erythema.
2:15 PM, approx 15 min. after H1N1 was administered, patient called stating that she felt tightness in chest and warmth in throat. Advised to call 911, go to nearest ER or MD office.
6 hours after - all over body aches. 24 hours after - exhaustion, muscle fatigue, body aches, swelling at site of injection. 30 hours after - severe headache, back of neck pain, right foot went numb for 20 minutes. 40 hours after - all of the above plus vomiting. 46 hours after - all of the above plus left hand went numb for 5 minutes.
This spontaneous report as received from registered nurse refers to a patient of unknown demographics. On 19-AUG-2014 the patient was vaccinated with PNEUMOVAX23 (lot # J006921, expiration date: 09-AUG-2014) 0.5ml (route of administration unspecified). On 19-AUG-2014, the patient was inadvertently administered with expired PNEUMOVAX23. It was reported that dose was supported. No adverse experience reported. The outcome of event was unknown. No product quality complaint was reported. Additional information has been requested.
1st and 2nd dose in 2019, has shingles/suspected vaccination failure; shingles rash internal and external from groin area to her knee/shingles rash on her left leg; severe groin pain; severe abdominal pain; This case was reported by a consumer via call center representative and described the occurrence of vaccination failure in a 66-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis.   Co-suspect products included Herpes zoster (Shingrix) for prophylaxis.   On an unknown date, the patient received the 2nd dose of Shingrix (intramuscular) .5 ml and the 1st dose of Shingrix (intramuscular) .5 ml. On 14th October 2022, more than 2 years after receiving Shingrix and Shingrix, the patient experienced vaccination failure (serious criteria GSK medically significant), shingles, groin pain and abdominal pain. The patient was treated with analgesic, nos (Pain Medication). On an unknown date, the outcome of the vaccination failure was unknown and the outcome of the shingles, groin pain and abdominal pain were not recovered/not resolved.   It was unknown if the reporter considered the vaccination failure, shingles, groin pain and abdominal pain to be related to Shingrix and Shingrix.     Additional Information: GSK Receipt Date: 02-NOV-2022 Reporter's Comment: The case was self reported by the patient. The patient received both the first and second dose of Shingrix in 2019 according to schedule into an unknown arm and more than 2 years she awoke to severe groin and abdominal pain and a shingles rash on left leg. The patient's daughter drove her to the emergency room and the patient was diagnosed with shingles both internal and external. The patient reported she was still in pain (abdominal and groin) and still had a shingles rash from her groin area down to just below her left knee.  The ER doctor gave her pain medications and antivirals. The reporter did not give permission to contact HCP. Additional Supportive Information: This case was considered as suspected vaccination failure as details regarding laboratory test and time to onset confirming shingles were unknown at the time of reporting.
A 67-year-old female patient, with a history of atrial fibrillation, received an intramuscular right deltoid injection of Fluzone (lot number U2165CA) on 31 October 2006, at 1:30 pm. By 8:00 pm, the patient reported that "her heart was racing". This continued for two days, and the patient called her primary care physician and was informed that "it would subside". She subsequently travelled to visit her daughter, and while there experienced a heart attack (dates not provided). According to the patient, she was hospitalized for one week and underwent a "full cardiac work-up"; the events were considered to be resolved. Concomitant medications included Coumadin, Diovan, and Toprol XL.
Pneumonia vaccine given approximately 2 PM on 10/24/2001 in left deltoid. Arm was slightly tender. On morning of 10/26/2001, he noticed soreness and visible swelling on inner aspect above left elbow discomfort. Did not call doctor's office.
1/2 hrs p/vax given pt went to sleep 1 hr later woke, vomitted, went back to sleep; 1 hr later woke vomitted went back to sleep; t102.5; mom gave APAP; pt cranky & fussy; pt had runny nose; pt appeared febrile, lethargic & floppy;
mentioned that both Havrix and an IPV vaccine was also administered at the same time on the same day (8/31/23) as the Pediarix dose; Pediarix dose was inadvertently administered to a 7 year old patient on 8/31/23 instead of the intended Boostrix; Pediarix dose was inadvertently administered to a 7 year old patient on 8/31/23 instead of the intended Boostrix; This non-serious case was reported by a other health professional via call center representative and described the occurrence of accidental overdose in a 7-year-old male patient who received DTPa-HBV-IPV (Pediarix) for prophylaxis.   Co-suspect products included POLIOMYELITIS VACCINE INACTIVATED (IPV) (batch number 25L32, expiry date 28-MAR-2025) for prophylaxis.   On 31-AUG-2023, the patient received Pediarix (right arm) and IPV (right arm). On 31-AUG-2023, an unknown time after receiving Pediarix, the patient experienced accidental overdose (Verbatim: mentioned that both Havrix and an IPV vaccine was also administered at the same time on the same day (8/31/23) as the Pediarix dose), wrong vaccine administered (Verbatim: Pediarix dose was inadvertently administered to a 7 year old patient on 8/31/23 instead of the intended Boostrix) and inappropriate age at vaccine administration (Verbatim: Pediarix dose was inadvertently administered to a 7 year old patient on 8/31/23 instead of the intended Boostrix).  The outcome of the accidental overdose, wrong vaccine administered and inappropriate age at vaccine administration were unknown.   Additional Information: GSK Receipt Date: 01-SEP-2023 Medical Assistant called to inquire about what to look for in the patient. How to proceed.  The health care professional reported that a Pediarix dose was inadvertently administered to a 7 year old patient received instead of the intended Boostrix, which led to wrong vaccine administered and inappropriate age at vaccine administration.  The Boostrix dose was not administered but health care professional mentioned that both Havrix and an IPV vaccine was also administered at the same time on the same day as the Pediarix dose which led to accidental overdose for IPV antigen.  The health care professional declined follow-up from Safety.
29jan90 pt vax hepta B. 07feb90 pt devel hives around mid-torso w/ itching.  pt treated w/ cortisone cream. pt presented to md office and a diagnosis of probable contact dermatitis was made.  pt recovered. 21feb90 pt vax 2nd hepta B.No prob
G62.9 PERIPHERAL NEUROPATHY 3/27/2023 CHF (CONGESTIVE HEART FAILURE), UNSPECIFIED I24.8 DEMAND ISCHEMIA 3/27/2023 CHF (CONGESTIVE HEART FAILURE), UNSPECIFIED
Information has been received from a nurse via Poison and Drug Center (PDC) (MFR# US15-036291) referring to a patient of unknown gender, between the age of 2 years and 5 years old. The relevant medical history, past drug history and concomitant medication were unknown. The reporter stated the single-dose vial of PROQUAD (Merck) underwent temperature excursions as follows: on 26-MAY-2015, 5.3 degrees Celsius for 2 hours and 8 minutes. On 30-JUN-2015 the patient was vaccinated with the improperly stored PROQUAD (Merck) lot # K014798, expiration date: 12-MAR-2016 (strength and dose not reported). No adverse event was reported. This is one of the eight reports reported by the same Nurse. Additional information has been requested.
N17.9 - AKI (acute kidney injury)  N17.9 - Acute kidney failure, unspecified E87.1 - Hypo-osmolality and hyponatremia
2 hours after vaccination. Patient became sweaty, chills, nausea with vomiting and flank pain. 3 hours after reporting, nausea and chills had subsided, but flank pain was still present.
Headache; Fever; This spontaneous case was reported by a consumer and describes the occurrence of PYREXIA (Fever) and HEADACHE (Headache) in a 40-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No medical history provided.    On 19-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 16-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 16-Apr-2021,  after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced PYREXIA (Fever). On 17-Apr-2021, the patient experienced HEADACHE (Headache). The patient was treated with PARACETAMOL (TYLENOL) ongoing since an unknown date at an unspecified dose and frequency. At the time of the report, PYREXIA (Fever) and HEADACHE (Headache) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 16-Apr-2021, Body temperature: 102 f (High) Fever of 102 F.         No concomitant medication provided.   This case was linked to MOD-2021-211623 (Patient Link).
Patient reported a dime size lump under the left arm ampit that is painful a day after the shot. No pain at the injection site.  Pain worsened after putting an ice pak on it. Lump was not there prior to getting the covid booster shot
This spontaneous report as received from a physician via a company representative refers to 7 patients of unspecified ages ranging "from 12 months to 48 months". On an unknown date the patients were vaccinated with first dose of VARIVAX (Merck) (lot number, strength, dose, route and site unspecified). In June 2012 the patients developed chickenpox. The outcome of chickenpox was unknown. It was unspecified if the patients had sought medical attention. Additional information has been requested.
Information has been received from a physician concerning a male patient who in approximately May 2007, was vaccinated with a dose of Zostavax. It was reported that in approximately May 2007, the patient experienced significant redness, warmth, and pain 48 hours post-injection. The patient was diagnosed with cellulitis and was treated with cephalexin (KEFLEX). At the time of report, the patient was recovering. A product quality complaint was not involved. Cellulitis was considered to be an other important medical event by the reporter. This is one of the several reports received from the same source. Additional information has been requested.
This spontaneous report was received from a consumer regarding a male patient of unknown age. No concurrent condition and historical medication was reported. On an unknown date, the patient was vaccinated with ZOSTAVAX. No concomitant medication was reported. On an unknown date, the patient experienced mild tingling in his arm. The outcome of mild tingling in his arm was unknown. No product quality was involved. Causality between mild tingling in his arm and zoster vaccine live was not reported. Additional information has been requested.
2 hours post vax he began vomiting and every time he moved his legs he cried. She called her doctor he told her to report this to the health department. She said he was okay. However today 10/4 he is vomiting again.
she fainted; had striped redness; swelling along her lateral deltoid extending to her medial bicep; unable to get up; This case was reported by a other health professional via call center representative and described the occurrence of fainting in a 63-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis.   On 2nd December 2021, the patient received the 2nd dose of Shingrix (intramuscular) 50 µg. On 3rd December 2021, 1 days after receiving Shingrix, the patient experienced erythema, peripheral swelling and mobility decreased. On 3rd December 2021 04:00, the patient experienced fainting (serious criteria hospitalization and GSK medically significant). On an unknown date, the outcome of the fainting and mobility decreased were unknown and the outcome of the erythema and peripheral swelling were recovered/resolved.   It was unknown if the reporter considered the fainting, erythema, peripheral swelling and mobility decreased to be related to Shingrix.  Additional details were provided as follows: The patient self-reported this case, who was an health care professional (HCP)/physical therapist. The patient received her 2nd dose of Shingrix in her left deltoid intramuscularly and next day around 4am,  she fainted and was unable to get up and she was taken to the hospital.  The patient reported that one episode of fainting, however her physician was requiring her to get an MRI and cardiac workup.  The patient's physician had also taken away her driving privileges for 2 months.  The patient stated she also had striped redness and swelling along her lateral deltoid extending to her medial bicep that took 2 to 3 days to resolve. The patient gave consent to contact her, but not her HCP and did not provide her email or doctor's demographics. She could not provide the lot or expiration date of the Shingrix vaccine she was administered Emergency room (ER) visit was required. The reporter consented to follow up.
Immediately after getting the shot, I experienced dizziness, nausea, a wierd taste in my mouth,, and my tongue felt numb. The day after I recieved the covid vaccine Janssen, I started noticing the injection site getting red and swollen. By the next day it had grown in size and was itching rather badly. I could sleep from how badly it was itching and burning. It has been 6 days since I got the vaccine and it's still large and swollen and really itchy. I have been taking ibuprofen for the pain and using benadryl for the itching.
Developed a painful herpes rash; Developed a painful herpes rash; This case was reported by a consumer and described the occurrence of herpes virus infection in a 60-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis.   On an unknown date, the patient received the 2nd dose of Shingrix. On an unknown date, unknown after receiving Shingrix, the patient experienced herpes virus infection and painful rash. The patient was treated with antivirals nos (Anti-Viral Medicine (Nos)). On an unknown date, the outcome of the herpes virus infection and painful rash were not recovered/not resolved.   It was unknown if the reporter considered the herpes virus infection and painful rash to be related to Shingrix.  Additional details were provided as follows: This case was reported by patient herself. The age at vaccination was not reported. The patient received her second shingrix vaccine and she had developed a painful herpes rash that had not resolved till the reporting date. The physician had prescribed her an antiviral, but she did not know the name of the medication.  No other information was provided. The reporter did not consent to follow-up.
Patient was admitted to the hospital on 10/14/2021 with SOB and hypoxia.  He was intubated and on a ventilator from 10/14/2021 to 10/18/2021.  He received 5 days of remdesivir, glucocorticoids x 22 days.   Patient was still on oxygen via heated high flow at the time of discharge to a long term acute care hospital.   Discharge diagnosis was acute respiratory failure with hypoxia and septic shock due to COVID-19 pneumonia.
This spontaneous report as received from a pharmacist refers to a newborn male patient of unknown age. On 08-OCT-2012 11:54, the patient was vaccinated with RECOMBIVAX HB that had been exposed to temperatures below 32F for 6 hours. During that 6 hour time period, the vaccine was exposed to 28.8F for 1.5 hours. Administration route was not reported. Two lot# were involved and the lot# were reported as: 0294AE, expiry date on 06-SEP-2014; and 0385AE, expiry date on 08-NOV-2014. It was unspecified which lot# the patient was administered. The outcome of event was unknown. It was unspecified if the patient sought medical attention. This is one of several reports received from the same source. Additional information has been requested.
pt recvd vax & devel redness & pain at inject site; nausea, dizziness, difficulty concentrating, fatigue, hypertension & dec appetite & 20 pound weight loss; MD dx as depression & prescribed prozac;
4-6-07 8:45 AM parents present with child at PH services questioning the red swollen arm of PT L deltoid.
Sleeping, diarrhea, nausea, vomiting, 2 febrile seizures, loss of consciousness, headaches, high-pitched screaming, sleep 3 hours, up for 4 screaming joint pain, dizziness, falling wide gait, eye conjunctivitis of yellowish-orange coloration, lucid eye movement, temperatures, lack of appetite, diagnosed with cerebellar ataxia, loss of speech & slurred speech. Head banging & backwards walking, swelling of face, rash for two weeks, and redness of left thigh.
Severe headache, chills, sweating, stomach upset, altered mental state, vision impairment, shaking. Started 30 minutes after injection and increased in severity over the next 48 hours then began to decrease. Headache is still present 4 days after injection.
Sore arm, fever, aches, headache, nausea, diarrhea, severe joint aches, sneezing, coughing, 3 to 4 days and counting
Cough, Wheezing, and Confirmed Pneumonia by chest x-ray.
Feel sicker than she had ever felt before; This case was reported by a consumer via interactive digital media and described the occurrence of sickness in a female patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received Shingles vaccine. On an unknown date, unknown after receiving Shingles vaccine, the patient experienced sickness. On an unknown date, the outcome of the sickness was unknown.   It was unknown if the reporter considered the sickness to be related to Shingles vaccine.  Additional details were reported as follows: The age at vaccination was not reported. The reporter said that my neighbor had the Shingles shot made her feel sicker than the patient had ever felt before. But then the reporter added, might be the patient, spy skilled in the art of propaganda. The information regarding consent to follow up was not reported.
Patient received booster shot earlier than 6 months from second dose. Patient should have been denied until October. No other issues.
sore and itching at injection site Narrative:  Per nursing report: "received [1st] Moderna vaccine February 22nd. C/o sore itchy left arm, warm to touch. A febrile."  Other Relevant History: